Hariharan, R.; Mousa, A.; Menon, K.; Feehan, J.; Ukropcová, B.; Ukropec, J.; Schön, M.; Majid, A.; Aldini, G.; de Courten, M.;
et al. Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial. Pharmaceuticals 2025, 18, 630.
https://doi.org/10.3390/ph18050630
AMA Style
Hariharan R, Mousa A, Menon K, Feehan J, Ukropcová B, Ukropec J, Schön M, Majid A, Aldini G, de Courten M,
et al. Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial. Pharmaceuticals. 2025; 18(5):630.
https://doi.org/10.3390/ph18050630
Chicago/Turabian Style
Hariharan, Rohit, Aya Mousa, Kirthi Menon, Jack Feehan, Barbara Ukropcová, Jozef Ukropec, Martin Schön, Arshad Majid, Giancarlo Aldini, Maximilian de Courten,
and et al. 2025. "Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial" Pharmaceuticals 18, no. 5: 630.
https://doi.org/10.3390/ph18050630
APA Style
Hariharan, R., Mousa, A., Menon, K., Feehan, J., Ukropcová, B., Ukropec, J., Schön, M., Majid, A., Aldini, G., de Courten, M., Cameron, J., Bell, S. M., & de Courten, B.
(2025). Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial. Pharmaceuticals, 18(5), 630.
https://doi.org/10.3390/ph18050630